LSD Trace Analysis, Urine
Use
This test is used for the detection of lysergic acid diethylamide (LSD) and its derivatives in urine samples. It is primarily utilized as a drug screening tool to identify the presence of LSD, which is known for its hallucinogenic properties. This analysis can be significant for clinical assessments in suspected substance abuse cases, as well as for monitoring purposes in rehabilitation programs. Detecting LSD in urine is valuable for diagnosing intoxication and understanding a patient's exposure history.
Special Instructions
Not provided.
Limitations
The test will not detect the parent LSD compound if it is not present in sufficient amounts in the urine. False negatives may occur if the specimen is collected too long after use, as LSD is rapidly metabolized and cleared from the body. Analytic interferences, such as gross hemolysis or lipemia, can hinder accurate measurement. Additionally, as an analyte specific reagent, performance characteristics have been established by the laboratory but have not received the rigors of FDA clearance or approval.
New York Approved
Methodology
Mass Spectrometry (LC-MS/MS)
Biomarkers
LOINC Codes
- 5679-6 - LSD Ur-mCnc
- 5679-6 - LSD Ur-mCnc
Result Turnaround Time
8-10 days
Related Documents
For more information, please review the documents below
Specimen
Urine
Volume
1 mL
Minimum Volume
0.5 mL
Container
Plastic preservative-free urine container
Collection Instructions
Collect 1 mL random urine without preservative. Send specimen refrigerated in a plastic, preservative-free urine container.
Causes for Rejection
Received in glass container.
Stability Requirements
| Temperature | Period |
|---|---|
| Refrigerated | 30 days |
| Frozen | 30 days |